A new research has revealed that proteins found in breast milk protect newborn infants from devastating intestinal disorder.
The study of Children's Hospital Los Angeles demonstrated that a protein called neuregulin-4 (NRG4) present in breast milk, but absent from formula, might be protective against the intestinal destruction caused in necrotizing enterocolitis (NEC), which is a lethal gastrointestinal disease.
Researcher Mark R. Frey said that the study suggests that without the NRG4 protein found in breast milk, a normal protection mechanism for the immature gut might be missing.
Frey added that if a baby on formula encountered an NEC trigger, such as intestinal infection or injury, he or she might be at increased risk for a life-threatening condition, whereas the protein, specifically with a receptor found in the intestine, ErbB4, blocks inflammatory intestinal damage.
Frey continued that they plan to evaluate NRG4 for its therapeutic potential in this disease.
The study is published in the American Journal of Pathology.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
